Double Blind, Investigation of Ondansetron in Schizophrenia
This study is completed in Australia. It is testing Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron for schizophrenia.
In Australia
Compare studies and check their requirements with the research team.
This study is completed in Australia. It is testing Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron for schizophrenia.
In AustraliaThis summary needs review. Please check the official study record and contact the research team for details.
In AustraliaThis summary needs review. Please check the official study record and contact the research team for details.
In AustraliaThis summary needs review. Please check the official study record and contact the research team for details.
In AustraliaThis summary needs review. Please check the official study record and contact the research team for details.
In AustraliaThis study was terminated in Australia. It is testing HB-1 for Anxiety.
In AustraliaThis study was terminated in Australia, in France, in Canada, .... It is testing Lu AA34893 for depression in bipolarity.
In AustraliaThis summary needs review. Please check the official study record and contact the research team for details.
In AustraliaThis summary needs review. Please check the official study record and contact the research team for details.
In AustraliaThis study is looking at further assess ERG components obtained with different ERG devices, to be considered in a prediction model for each diagnosis for people with Schizophrenia or Bipolarity I. Participants are followed over time so researchers can learn from clinical and follow-up information.
In AustraliaThis summary needs review. Please check the official study record and contact the research team for details.
In AustraliaThis summary needs review. Please check the official study record and contact the research team for details.
In AustraliaHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.